Simris Q2 FY26 operating loss narrows 19% to SEK 5.44 million; revenue drops 71% to SEK 196,000
Reuters2026/08/12 06:05- Simris Group reported Q2 net revenue down 71% to SEK 196,000 versus the year-earlier quarter.
- EBITDA loss narrowed 35% to SEK 1.93 million; operating loss improved 19% to SEK 5.44 million.
- First-half net revenue fell 27% to SEK 620,000; EBITDA loss narrowed 39% to SEK 4.11 million.
- Operating loss improved 21% to SEK 11.06 million; divestment talks advanced for Hammenhög assets with a second prospective buyer.
- Post-quarter, warrant holders signaled exercises totaling EUR 1 million; Andreas Pahl named CEO of Simris Biologics, Tiffany J. Vora appointed adviser.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lazard paper warns global supply chains face O-ring-style single-point failures amid geopolitics
Andalan Perkasa Abadi says unaware of material information behind NASA share volatility
Massive Buyback Faces "Cold Reception"! U.S. Treasury Bond Purchase Plan Hits a Wall, Liquidity Tool Risks Becoming Ineffective
The US Treasury's expanded repo operations faced a record-low subscription ratio, highlighting a bottleneck in long-term bond market absorption, which may force officials to further cut issuance of the less liquid 20-year US Treasury bonds.
Crypto prices
More
